Jundishapur Journal of Microbiology

Published by: Kowsar

Baculoviral Co-Expression of HA, NA and M1 Proteins of Highly Pathogenic H5N1 Influenza Virus in Insect Cells

Farida Behzadian 1 , Zahra Goodarzi 2 , Fatemeh Fotouhi 3 and Esmaeil Saberfar 2 , *
Authors Information
1 Malek Ashtar University, Research Center for Sciences and Biotechnology, Tehran, IR Iran
2 Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
3 Influenza Research Labs, Pasteur Institute of Iran, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: November 01, 2013, 6 (9); e7665
  • Published Online: November 1, 2013
  • Article Type: Research Article
  • Received: August 22, 2012
  • Revised: December 12, 2012
  • Accepted: January 12, 2013
  • DOI: 10.5812/jjm.7665

To Cite: Behzadian F, Goodarzi Z, Fotouhi F, Saberfar E. Baculoviral Co-Expression of HA, NA and M1 Proteins of Highly Pathogenic H5N1 Influenza Virus in Insect Cells, Jundishapur J Microbiol. 2013 ; 6(9):e7665. doi: 10.5812/jjm.7665.

Abstract
Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Munster VJ, Fouchier RA. Avian influenza virus: of virus and bird ecology. Vaccine. 2009; 27(45): 6340-4[DOI][PubMed]
  • 2. Alexander Dennis J. A review of avian influenza in different bird species. Vet Microbiol. 2000; 74(1): 3-13
  • 3. Knipe DM, Howley P. Fields Virology.: 2013;
  • 4. Wen Z, Ye L, Gao Y, Pan L, Dong K, Bu Z, et al. Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge. Antiviral Res. 2009; 84(3): 215-24[DOI][PubMed]
  • 5. Hitchman RB, Possee RD, Crombie AT, Chambers A, Ho K, Siaterli E, et al. Genetic modification of a baculovirus vector for increased expression in insect cells. Cell Biol Toxicol. 2010; 26(1): 57-68[DOI][PubMed]
  • 6. Ligon BL. Avian influenza virus H5N1: a review of its history and information regarding its potential to cause the next pandemic. Semin Pediatr Infect Dis. 2005; 16(4): 326-35[DOI][PubMed]
  • 7. Ellebedy AH, Webby RJ. Influenza vaccines. Vaccine. 2009; 27 Suppl 4-8[DOI][PubMed]
  • 8. Steel J. New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges. BioDrugs. 2011; 25(5): 285-98[DOI][PubMed]
  • 9. Lambert Linda C, Fauci Anthony S. Influenza vaccines for the future. New England J Med. 2010; 363(21): 2036-2044
  • 10. Berger I, Fitzgerald DJ, Richmond TJ. Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol. 2004; 22(12): 1583-7[DOI][PubMed]
  • 11. Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, et al. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine. 2007; 25(19): 3871-8[DOI][PubMed]
  • 12. Kang SM, Pushko P, Bright RA, Smith G, Compans RW. Influenza virus-like particles as pandemic vaccines. Curr Top Microbiol Immunol. 2009; 333: 269-89[DOI][PubMed]
  • 13. Ludwig C, Wagner R. Virus-like particles-universal molecular toolboxes. Curr Opin Biotechnol. 2007; 18(6): 537-45[DOI][PubMed]
  • 14. Krammer F, Grabherr R. Alternative influenza vaccines made by insect cells. Trends Mol Med. 2010; 16(7): 313-20[DOI][PubMed]
  • 15. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, et al. Short Protocols in Molecular Biology.: 2002;
  • 16. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;
  • 17. Aucoin MG, Mena JA, Kamen AA. Bioprocessing of baculovirus vectors: a review. Curr Gene Ther. 2010; 10(3): 174-86[PubMed]
  • 18. Trowitzsch S, Bieniossek C, Nie Y, Garzoni F, Berger I. New baculovirus expression tools for recombinant protein complex production. J Struct Biol. 2010; 172(1): 45-54[DOI][PubMed]
  • 19. Federico Maurizio. Virus-like particles show promise as candidates for new vaccine strategies. Future virology. 2010; 5(4): 371-374
  • 20. Latham T, Galarza JM. Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol. 2001; 75(13): 6154-65[DOI][PubMed]
  • 21. Galarza JM, Latham T, Cupo A. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol. 2005; 18(1): 244-51[DOI][PubMed]
  • 22. Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, et al. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS One. 2008; 3(1)[DOI][PubMed]
  • 23. Quan FS, Steinhauer D, Huang C, Ross TM, Compans RW, Kang SM. A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine. 2008; 26(26): 3352-61[DOI][PubMed]
  • 24. Sokolenko S, George S, Wagner A, Tuladhar A, Andrich JM, Aucoin MG. Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks. Biotechnol Adv. 2012; 30(3): 766-81[DOI][PubMed]
  • 25. Quan FS, Huang C, Compans RW, Kang SM. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol. 2007; 81(7): 3514-24[DOI][PubMed]
  • 26. Kang SM, Yoo DG, Lipatov AS, Song JM, Davis CT, Quan FS, et al. Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS One. 2009; 4(3)[DOI][PubMed]
  • 27. Pushko P, Tumpey TM, Bu F, Knell J, Robinson R, Smith G. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine. 2005; 23(50): 5751-9[DOI][PubMed]
  • 28. Pushko P, Tumpey TM, Van Hoeven N, Belser JA, Robinson R, Nathan M, et al. Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza. Vaccine. 2007; 25(21): 4283-90[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments